Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Therapeutic response unexpected
Clinical narrative: Patient's positional vertigo been cured (suffered from past two years)/ no longer suffer from vertigo; COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) and THERAPEUTIC RESPONSE UNEXPECTED (Patient's positional vertigo been cured (suffered from past two years)/ no longer suffer from vertigo) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included Vertigo positional.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Sep-2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Patient's positional vertigo been cured (suffered from past two years)/ no longer suffer from vertigo). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had resolved and THERAPEUTIC RESPONSE UNEXPECTED (Patient's positional vertigo been cured (suffered from past two years)/ no longer suffer from vertigo) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Aug-2022, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications were reported.  It was reported that patient was Moderna vaccinated and doubly boosted.  Patient had mild covid-19 symptoms. As soon as patient started taking the pills, the symptoms disappeared.  Company comment: This spontaneous case concerns a 70-year-old patient of unspecified gender with no medical history reported, who experienced the unexpected non-serious AESI of COVID-19 which occurred in context to a dose of mRNA-1273 vaccine. Latency cannot be assessed since vaccination date was not disclosed. SARS-CoV-2 test was Positive on 22-Aug-2022 which is 22 days prior to the onset of event. Additionally, Therapeutic response unexpected was also reported as an event. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID). No further details on clinical course, other lab test results were reported. The outcome of the events was reported as resolved. Current pandemic situation of COVID-19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 70-year-old patient with  unspecified gender, with no medical history reported, who experienced the unexpected non-serious AESI of COVID-19 which occurred in context to a dose of mRNA-1273 vaccine. Latency cannot be assessed since vaccination date was not disclosed. SARS-CoV-2 test was Positive on 22-Aug-2022 which is 22 days prior to the onset of event. Additionally, Therapeutic response unexpected was also reported as an event. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID). No further details on clinical course, other lab test results were reported. The outcome of the events was reported as resolved. Current pandemic situation of COVID-19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.